✦ LIBER ✦

Clinical assessment of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A

✍ Scribed by A. DMOSZYNSKA; K. KULICZKOWSKI; A. HELLMANN; J. TRELINSKI; J. KLOCZKO; T. BAGLIN; C. HAY; D. O’SHAUGHNESSY; K. ZAWILSKA; M. MAKRIS; R. SHAIKH-ZAIDI; E. GASCOIGNE; C. DASH

Book ID: 108775671
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 110 KB
Volume: 17
Category: Article
ISSN: 1351-8216
DOI: 10.1111/j.1365-2516.2010.02446.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of Optivate®, a high-pu

Pharmacokinetics of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in patients with severe haemophilia A

✍ A. DMOSZYNSKA; A. HELLMANN; T. BAGLIN; D. O’SHAUGNESSY; J. TRELINSKI; K. KULICZK 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

Experience with Optivate®, a new high pu

Experience with Optivate®, a new high purity concentrate of factor VIII with von Willebrand factor, in patients undergoing surgery

✍ C. R. M. HAY; A. HELLMANN; A. DMOSZYNSKA; T. BAGLIN; D. O’SHAUNESSEY; M. MAKRIS; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Clinical experience with Optivate®, high

Clinical experience with Optivate®, high-purity factor VIII (FVIII) product with von Willebrand factor (VWF) in young children with haemophilia A

✍ M. MATYSIAK; H. BOBROWSKA; W. BALWIERZ; A. CHYBICKA; J. R. KOWALCZYK; R. SHAIKH- 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Immune tolerance therapy utilizing facto

Immune tolerance therapy utilizing factor VIII/von Willebrand factor concentrate in haemophilia A patients with high titre factor VIII inhibitors

✍ M. A. H. KURTH; D. DIMICHELE; C. SEXAUER; J. M. SANDERS; M. TORRES; S. C. ZAPPA; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Immune tolerance induction with a high p

Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response

✍ A. GRINGERI; R. MUSSO; M. G. MAZZUCCONI; G. PISEDDU; M. SCHIAVONI; P. PIGNOLONI; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB

Immune tolerance induction with a factor

Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH®) in 14 patients with severe haemophilia A

✍ C. BIDLINGMAIER; K. KURNIK; C. ESCURIOLA-ETTINGSHAUSEN; R. JAGER; R. KLAMROTH; C 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB